2Suppliers
3Customers
1Debt Items
20Related Chains

Trinity Biotech plc Suppliers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% ur own direct sales force in the U.S. Our sales team in the U.S. is responsible for marketing and selling the Trinity Biotech range of point-of-care, infectious diseases, haemoglobins, autoimmune and…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from TRIB graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from TRIB graph: ur own direct sales force in the U.S.…

Trinity Biotech plc Customers

TickerNameConfidenceEvidence
GUANGZHOU-WONDFO-BIOTECH-CO-LTD GUANGZHOU-WONDFO-BIOTECH-CO-LTD 85% (Cobas, TinaQuant 3™), Bio-Rad (Variant 2™, Variant 2 Turbo™, D 100™, BioPlex 2200) Tosoh (G8™ and G11™), Arkray 8180™, Siemens DCA™, Sebia (Capyllaris 2™ and Capyllaris 3™), Shanghai Kehua Bio-Engin…
JNJ Johnson & Johnson 72% ur own direct sales force in the U.S. Our sales team in the U.S. is responsible for marketing and selling the Trinity Biotech range of point-of-care, infectious diseases, haemoglobins, autoimmune and…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from TRIB graph: ur own direct sales force in the U.S. Our sales team in the U.S. is responsible for marketing and selling the Trinity …

Trinity Biotech plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
TRIB-DEBT Debt stack $138.0M 90% Market cache reports total debt of $138.0M.

Trinity Biotech plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Trinity Biotech plc.

Trinity Biotech plc Ownership

HolderNameConfidenceEvidence
TRIB-OWNER-HUNTER-ASSOCIATES-INVESTMENT-MAN HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 90% 13F overlay lists HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC as top holder; 25 tracked holders.

Trinity Biotech plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ABBV AbbVie Inc. 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
ADGM Adagio Medical Holdings, Inc. 100.00 2
ACIU AC Immune SA 100.00 2
ATON AlphaTON Capital Corp 100.00 2
BLLN BillionToOne, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AURA Aura Biosciences, Inc. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
AORT Artivion, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
CRIS Curis, Inc. 100.00 2